ES317053A3 - A process for preparing new pharmaceutical compositions comprising compounds of 1,2-diphenyl-2-aciloxi3-methyl-N-butilamine. (Machine-translation by Google Translate, not legally binding)
- Google Patents
A process for preparing new pharmaceutical compositions comprising compounds of 1,2-diphenyl-2-aciloxi3-methyl-N-butilamine. (Machine-translation by Google Translate, not legally binding)
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and CofiledCriticalEli Lilly and Co
Priority to ES0317053ApriorityCriticalpatent/ES317053A3/en
Publication of ES317053A3publicationCriticalpatent/ES317053A3/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
A process for preparing new pharmaceutical compositions comprising 1,2-diphenyl-2-acyloxy-3-methyl-n-butylamine compounds, which is characterized by bringing to a therapeutically useful form of administration a compound selected from the group consisting of the alpha-d and alpha-l of a base represented by the formula ** (See formula) ** wherein R represents a radical of the group consisting of methyl and ethyl, and Am represents a radical of the group consisting of dimethylamino, dimethylamino-N-oxide, pyrrolidino and pyrrolidino-N-oxide, forming the 2-naphthalene sulfonate salt of said compound of base that has improved analgesic and antitussive properties. (Machine-translation by Google Translate, not legally binding)
ES0317053A1965-09-021965-09-02A process for preparing new pharmaceutical compositions comprising compounds of 1,2-diphenyl-2-aciloxi3-methyl-N-butilamine. (Machine-translation by Google Translate, not legally binding)
ExpiredES317053A3
(en)
A process for preparing new pharmaceutical compositions comprising compounds of 1,2-diphenyl-2-aciloxi3-methyl-N-butilamine. (Machine-translation by Google Translate, not legally binding)
A process for preparing new pharmaceutical compositions comprising compounds of 1,2-diphenyl-2-aciloxi3-methyl-N-butilamine. (Machine-translation by Google Translate, not legally binding)
A process for preparing new pharmaceutical compositions comprising compounds of 1,2-diphenyl-2-aciloxi3-methyl-N-butilamine. (Machine-translation by Google Translate, not legally binding)
A process for preparing new pharmaceutical compositions comprising compounds of 1,2-diphenyl-2-aciloxi3-methyl-N-butilamine. (Machine-translation by Google Translate, not legally binding)
A procedure for the preparation of N-substituted derivatives of compounds of 14-hydroxydehydronormorfin. (Machine-translation by Google Translate, not legally binding)
Procedure for preparing a hypercolesteremical composition of application in the form of unitary dose. (Machine-translation by Google Translate, not legally binding)